301080 Share Price Performance
Recent 301080 News & Updates
No updates
Acrobiosystems Co.,Ltd. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 22, 2025
- Earnings per share (EPS)
- 0.80
- Gross Margin
- 84.62%
- Net Profit Margin
- 19.51%
- Debt/Equity Ratio
- 2.0%
Acrobiosystems Co.,Ltd. Competitors
About 301080
- Founded
- 2010
- Employees
- 869
- CEO
- WebsiteView website
Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China.
Chinese Market Performance
- 7 Days: 1.4%
- 3 Months: 12.7%
- 1 Year: 30.0%
- Year to Date: 13.1%
Over the last 7 days, the market has risen 1.4%, driven by gains of 4.0% in the Information Technology sector. The market is up 30% over the last 12 months. As for the next few years, earnings are expected to grow by 23% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading